- Presentations
- 2
- Markets
- 1
Myfortic is a brand of Mycophenolate marketed by Novartis Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mycophenolate
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 180 mg delayed-release tablet, 360 mg delayed-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Myfortic 180 mg delayed-release tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Myfortic 360 mg delayed-release tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Mycophenolate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Myfortic
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.